About this event
Most biological systems have a specific and purposeful spatial organisation to them. The full intricacy of these interactions has, until recently, been largely untapped using bulk profiling methods. But single-cell analysis and spatial profiling have changed the game.
To explore how to utilise these technologies to their best potential, and discover how your peers are using new spatial approaches to uncover the intricate details of complex systems, register for the next series of Spatial Biology ONLINE.
Across this 3-part series, you will uncover how spatial technologies are fuelling the next era of biomedical research, and how you can gather useful insights from the most complex of molecular datasets.
Thursday 15th of December, 3pm GMT/ 4pm CET/ 10am EST
Research is showing that cancer onset and progression are driven by an array of factors. Spatial technologies have been uncovering how some of these interactions are contributing to the disease.
In this webinar, we will focus on the application of spatial biology in studying cancers and how this is leading to novel findings and opportunities for drug discovery and precision medicine.
TALK 1: Spatial heterogeneity in glioblastoma – Vidhya Ravi, Clinical Scientist, University of Freiburg Medical Centre
TALK 2: Advances in Spatial Immuno-Oncology using ChipCytometry™ - Tim Sindelar, Product Manager, Canopy Biosciences
TALK 3: The power of spatial analytics for exploration of urologic cancers – Evan Keller, Professor of Urology and Pathology, Director, Single Cell Spatial Analysis Program, University of Michigan
TALK 4: Analysis platforms to quantify tumour-immune interactions through spatial profiling technologies - Arvind Rao, Associate Professor, University of Michigan
Now available on demand
Spatial biology can give the new, highly granular insights to better understand markers of disease onset and progression and, ultimately, drive our drug discovery efforts towards better drug targets. These technologies have therefore become an invaluable tool for drug hunters and pharmaceutical companies.
In this webinar, the application of spatial technologies in the context of drug discovery will be discussed and include examples of key case studies.
TALK 1: Spatial analysis to understand disease biology and supporting drug discovery - Elton Rexhepaj, Director of Data Science, Bioimaging and Computational Pathology, Sanofi
TALK 2: Spatial proteogenomics approaches for immunotherapy…and COVID-19 - Arutha Kulasinghe, NHMRC Research Fellow, Clinical-oMx Group Leader, The University of Queensland Diamantina Institute
TALK 3: Using single cell and spatial technology in the developing human brain – Jasmine Plummer, Founding Director, Center for Spatial OMICS, St Jude Children's Research Hospital
Now available on demand
The spatial organisation of certain systems, such as complex tissues such as the brain or the tumour microenvironment, plays a key role in the maintenance of healthy tissues or the progression of diseases.
In this webinar, we highlight ground-breaking research into how spatial information is being derived for the most complex and intricate of systems, and how these can translate into opportunities for future research and clinical intervention. .
TALK 1: The concordance of imaging-based spatial transcriptomics with single-cell RNA sequencing - Jonathan Liu, Data Scientist, Computational Biology, Chan Zuckerberg Biohub
TALK 2: Welcome to the Resolution Revolution - Wieland Keilholz - Spatial Market Development Manager, 10x Genomics
TALK 3: Dissecting mechanisms of metabolic liver zonation and regeneration using Spatial Tx - Jan Tchorz, Associate Director, Liver Research, Novartis
TALK 4: Spatial approaches to 3D cell models - Anka Erhardt, Director, Cell-Based Sciences, Merck
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.